Unveil Pharma
Venture capitalCambridge · 1 people tracked
Investment thesis
Unveil Pharma is a Boston-area biotech investor that sources deals from research institutions such as Harvard, MIT, and the Wyss Institute. It focuses on drug-development assets between the IND and Phase II stages, targeting exits within roughly five years, and provides operational support in drug development and commercialization. The firm also has a presence in Singapore.
Team · 1 people
from the firm's websiteFrequently asked questions
- What sectors does Unveil Pharma focus on?
- Unveil Pharma focuses on Biotech.
- Where is Unveil Pharma located?
- Unveil Pharma is headquartered in Cambridge, US.
Similar investors
8VC is a technology investment firm that builds and invests in ambitious companies across sectors including life sciences, healthcare, manufacturing, enterprise, logistics, and defense.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.
B Capital Group is a multi-stage venture capital firm that backs founders across the company-building lifecycle, investing in technology, healthcare, and energy & resilience sectors.